EMILY MILLER: Open Payments
NPI 1528396207 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,439 in 80 payments from 16 companies in 2025. Trend: 2023 $1,988 · 2024 $2,883 · 2025 $1,439
Food & beverage: $1,396Education: $43
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $290 |
| ABBVIE INC. | 20 | $245 |
| Novartis Pharmaceuticals Corporation | 9 | $185 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $141 |
| GENZYME CORPORATION | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $87 |
| Lilly USA, LLC | 3 | $56 |
| PFIZER INC. | 3 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, COSENTYX, RINVOQ, ILUMYA, CIBINQO, Sotyktu.
Industry payments across IN — which companies pay providers there.
